This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
BioPharm America™ 2019

SPECIAL REPORT: 2019 Biopharma Outlook Facing an Uncertain Future

Posted by on 20 May 2019
Share this article

Report by:SPECIAL REPORT: 2019 Biopharma Outlook Facing an Uncertain Futurexconomy-logo

High anxiety. This may best capture the current mood of many in the biotech industry. The following Xconomy Special Report takes a deep dive into the emerging issues posing an existential threat to the health of our industry. It is a worthy read. In times of crisis, effective preparedness is key.

In this Report, veteran biotech journalists Alex Lash and Ben Fidler bring you deep insights, based on conversations with key industry leaders, on what 2019 and beyond hold for biopharma companies. You’ll learn:

• The key indicators that suggest a possible downturn is on the way.

• What biopharma leaders, Jim Greenwood of BIO, Abbie Celniker of Third Rock Ventures, and others, are saying about what these uncertain times mean for the industry.

• Practical tips for young companies and investors on how to brace for rough seas ahead.

Download Now -  SPECIAL REPORT: 2019 Biopharma Outlook Facing an Uncertain Future

Once prepared, learn more on how you can join innovative life science leaders to drive even more breakthroughs in drug development through networking and partnering at BioPharm America™,  September 11—12 in Boston.

BPA19 Banner Mockup_728x90 (003)

Share this article

Sign up for Partnering, Business Development & Licensing email updates